Grant: Project Grant

Many current therapeutics are peptides including well-known drugs such as insulin. These have a number of issues, mostly related to their poor stability, hence require frequent and large dosing, as well as having poor storage properties. We here present an integrated platform to both discover peptides with new effects as well as to optimize their drug-like properties. Our methods are based on technologies that we previously developed and include state-of-the-art cell culture screening techniques as well as methods derived from artificial intelligence to find optimal novel peptide drugs. A unique aspect of our approach is the tight integration of these advanced methods, which will help us on our mission to develop novel therapeutics.